Sampathkumar Devarajan

Title: Inventor Spotlight: Sampathkumar Devarajan

Introduction: Sampathkumar Devarajan is an innovative inventor located in Chennai, India, recognized for his contributions to the field of pharmaceuticals. With a focus on enhancing drug delivery mechanisms, he has made significant strides in transdermal drug systems.

Latest Patents: Devarajan holds a patent for the "Composition of dexibuprofen transdermal hydrogel." This groundbreaking invention details a stable, non-alcoholic transdermal hydrogel formulation of dexibuprofen, developed through a simple manufacturing process. Experimental trials demonstrated that essential excipients, such as a pH modifying agent, antioxidant, and a water miscible solvent, were crucial in achieving the hydrogel's stability. Notably, when carbopol was used as a gelling polymer, the resulting product was an opaque gel, while hydroxypropyl methylcellulose (HPMC) yielded a transparent gel. Stability studies indicated no significant changes in physical characteristics, pH, assay, or related substance values after three months in accelerated conditions.

Career Highlights: Currently, Sampathkumar Devarajan works at Strides Shasun Limited, a prominent name in the pharmaceutical sector. His work advancing drug formulations has distinguished him within his organization and the wider industry.

Collaborations: Devarajan collaborates with notable colleagues, including Jeffrey Stuart Bergman and Selvakumar Ramalingam. Their combined expertise fosters a creative environment that promotes innovative solutions in pharmaceutical development.

Conclusion: Sampathkumar Devarajan exemplifies the spirit of innovation in the pharmaceutical field. His contributions through the patent for dexibuprofen transdermal hydrogel highlight the importance of ongoing research and development in improving drug delivery systems for better patient outcomes. As the pharmaceutical landscape continues to evolve, inventors like Devarajan play a crucial role in shaping the future of healthcare.